CXCR4 and osteosarcoma: A similar conclusion was observed in osteosarcoma, where Feig et al. (2013) showed that the SDF-1/CXCR4 axis facilitates the accumulation of myeloid-derived suppressor cells in the TME to abate the response to anti-PD-1 therapy.